Activities of Marina YANNAKOUDAKIS related to 2013/2022(INI)
Shadow reports (1)
REPORT on the report from the Commission to the Council on the basis of Member States' reports on the implementation of the Council Recommendation (2009/C 151/01) on patient safety, including the prevention and control of healthcare- associated infections PDF (244 KB) DOC (139 KB)
Amendments (31)
Amendment 2 #
Motion for a resolution
Citation 6 a (new)
Citation 6 a (new)
- having regard to the Directive on Patients Rights in Cross Border Healthcare (2011/24/EU),
Amendment 11 #
Motion for a resolution
Citation 1 a (new)
Citation 1 a (new)
- having regard to the Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine[1] (2002/77/EC) and to the European Parliament resolution of 23 October 2001 on the proposal for that recommendation (COM(2001)0333), [1] OJ L 34, 5.2.2002, p.13
Amendment 12 #
Motion for a resolution
Citation 3 a (new)
Citation 3 a (new)
- having regard to the second report from the Commission to the Council of 9 April 2010 on the basis of Member States' reports on the implementation of the Council recommendation (2002/777/EC) on the prudent use of antimicrobial agents in human medicine[1], and to the Commission staff working document accompanying that report[2], [1]http://ec.europa.eu/health/antimicrobia l_resistance/docs/amr_report2_en.pdf [2]http://ec.europa.eu/health/antimicrobia l_resistance/docs/cswd_technicalannex_e n.pdf
Amendment 14 #
Motion for a resolution
Citation 4 a (new)
Citation 4 a (new)
- having regard to the Commission communication of 15 November 2011 on an action plan against the rising threats from antimicrobial resistance (COM(2011)0748),
Amendment 18 #
Motion for a resolution
Citation 4 b (new)
Citation 4 b (new)
- having regard to the Joint Technical Report by the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) of 17 September 2009 on 'The bacterial challenge: time to react – A call to narrow the gap between multidrug- resistant bacteria in the EU and the development of new antibacterial agents',
Amendment 105 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the steps taken by the Commission to improve general patient safety by promoting mutual learning between Member States and putting forward commondevising definitions and terminology for patient safety;
Amendment 107 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Criticises the factRecognises that, to date, no classification for patient safety has been proposed at EU level for the purpose of identifying, understanding and analysing the factors involved in patient safety, with a view to learning and improving the relevant systems;
Amendment 109 #
Motion for a resolution
Paragraph 4 – introductory part
Paragraph 4 – introductory part
4. Criticises the factAcknowledges that, to date, too few Member States
Amendment 112 #
Motion for a resolution
Paragraph 5
Paragraph 5
5. Welcomes the Commission's work on HAI prevention and control, as well as the coordination and surveillance efforts of the European Centre for Disease Prevention and Control (ECDC) in this connectionwork conducted by the European Centre for Disease Prevention and Control (ECDC) in conjunction with health authorities in the Member States on HAI prevention and control;
Amendment 126 #
Motion for a resolution
Paragraph 10 – indent 4 a (new)
Paragraph 10 – indent 4 a (new)
- support multidisciplinary wound care as part of patient safety programmes at the Member State level;
Amendment 135 #
Motion for a resolution
Paragraph 12
Paragraph 12
Amendment 140 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. UrgesCalls on the Commission to consider once again the calls for the introduction ofassess the feasibility and costs of establishing a database listing goodbest practices with a view to fostering exchanges of such practices among the Member States;
Amendment 143 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Calls onEncourages the Member States to prioritiseshare best practices through a data-based approach and, in particular, to draw up, on the basis of case studies and feedback, common guidelines applicable throughout the Union;
Amendment 150 #
Motion for a resolution
Paragraph 16 – indent 3
Paragraph 16 – indent 3
– support research into the prevention and control of HAIs, particularly those caused by Methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and other emerging difficult-to-treat infections;
Amendment 152 #
Motion for a resolution
Paragraph 17
Paragraph 17
Amendment 154 #
Motion for a resolution
Paragraph 18
Paragraph 18
Amendment 171 #
Motion for a resolution
Paragraph 21
Paragraph 21
21. Calls on theHighlights the need for Member States to use the most advanced technological means available to guarantee optimum patient safety, and, in particular, to introduce across the board electronic health passports containing all relevant information about the patient, including his or her antecedents;
Amendment 174 #
Motion for a resolution
Paragraph 22 – introductory part
Paragraph 22 – introductory part
22. EmphasisAcknowledges, as regards home care, that:
Amendment 184 #
Motion for a resolution
Paragraph 23
Paragraph 23
23. Calls onRecommends that the Member States to carry ouconduct specific awareness-raising and training measures concerning HAIs which are aimed not only at healthcare professionals (doctors, nurses, paramedics, etc.), but also, for example, at carers;
Amendment 188 #
Motion for a resolution
Paragraph 24
Paragraph 24
Amendment 192 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Calls on theEncourages Member States to provide patients with information about risks, safety levels and the measures taken to prevent adverse events in healthcare, in order to ensure that patients can give informed consent to the treatment they are being offered and, more generally, to enable patients to learn more about the issue of patient safety, and urges them to; requests that Member States inform patients about complaints procedures and the legal remedies options available to them should adverse events in healthcare occur;
Amendment 202 #
Motion for a resolution
Paragraph 27
Paragraph 27
Amendment 208 #
Motion for a resolution
Paragraph 28
Paragraph 28
Amendment 212 #
Motion for a resolution
Paragraph 29
Paragraph 29
29. Urges the Member States to adopt standardised criteria to identify places where contamination with HAIs occurs (including facilities outside hospitals) and to continue their efforts to collect comparable, up-to-date information on general patient safety and HAIsEmphasises the importance of establishing an effective European network of national surveillance systems to identify places where contamination with HAIs occur in order to collect comparable, up-to-date reference data;
Amendment 216 #
Motion for a resolution
Paragraph 30
Paragraph 30
30. Calls in particular on those Member States which conduct specific national HAI prevalence surveys using a harmonised ECDC methodology developed by the ECDC to do so on a regular basis, and ; encourages thoseall Member States which do not do so to introduce such surveys;
Amendment 218 #
Motion for a resolution
Paragraph 31
Paragraph 31
Amendment 221 #
Motion for a resolution
Paragraph 32
Paragraph 32
32. Calls on the Member States and the Commission to step up cooperation, including with the WHO and the OECD, with a view to standardising measures,, in conjunction with the WHO and the OECD, to improve cooperation with a view to developing standardised definitions, terminology and indicators in the area of patient safety;
Amendment 226 #
Motion for a resolution
Paragraph 34
Paragraph 34
34. Encourages the ECDC in its efforts to support and standardise the monitoring of HAIs, and, in particular, calls on it to continue developing structure and process indAcknowledges the importance of the ECDC's Antimicrobial Resistance and Healthcare-associated Infections Programme (ARHAI) particularly in its efforts to support and standardise the monitoring of HAIs, offer scientific advice, and provide training and communicatorsion;
Amendment 228 #
Motion for a resolution
Paragraph 35
Paragraph 35
Amendment 238 #
Motion for a resolution
Paragraph 36
Paragraph 36
36. Urges the Member States and the Commission to extend by a minimum of at least two yearsconsider extending the monitoring of the action taken to implement the recommendation on patient safety, including the prevention and control of HAIs;
Amendment 239 #
Motion for a resolution
Paragraph 37
Paragraph 37
37. Urges the Member States to step up their cooperation with the ECDC in the area of the prevention and control of HAIs; encourages national authorities in particular to ask the ECDC to carry out regular in situ audits and to publish the reports submitted to them by the ECDC, and emphasises, in that connection, the need to ensure, under future multiannual financial frameworks, that the ECDC receives the long-term funding it needs to fulfil its coordination and monitoring remit;